Madrid

The trials here

What the 3 trials at this site are about, from their registry records.

Conditions

• Acute myeloid leukaemia1 trial
• Bladder cancer1 trial
• Metastatic breast cancer1 trial

Phase

• Phase 32 trials
• Phase 21 trial

Status

• Completed3 trials

Lead sponsor

• Astellas Pharma Global Development, Inc.3 trials

Closed trials

• Completed

  A Study to Evaluate Enfortumab Vedotin Versus (vs) Chemotherapy in Subjects With Previously Treated Locally Advanced or Metastatic Urothelial Cancer (EV-301)

  NCT03474107· Phase 3· Astellas Pharma Global Development, Inc.· Source

• Completed

  A Study of ASP2215 (Gilteritinib) by Itself, ASP2215 Combined With Azacitidine or Azacitidine by Itself to Treat Adult Patients Who Have Recently Been Diagnosed With Acute Myeloid Leukemia With a FLT3 Gene Mutation and Who Cannot Receive Standard Chemotherapy

  NCT02752035· Phase 3· Astellas Pharma Global Development, Inc.· Source

• Completed

  A Study to Assess the Efficacy and Safety of Enzalutamide With Trastuzumab in Patients With Human Epidermal Growth Factor Receptor 2 Positive (HER2+), Androgen Receptor Positive (AR+) Metastatic or Locally Advanced Breast Cancer

  NCT02091960· Phase 2· Astellas Pharma Global Development, Inc.· Source